📗 Cite This Artifact
CLEC7A / Dectin-1 Protein
CLEC7A / Dectin-1 Protein
Overview
CLEC7A (Dectin-1) is a type II transmembrane C-type lectin receptor (CLR) expressed primarily on [microglia](/cell-types/microglia) and other myeloid cells. Dectin-1 is the defining surface marker of disease-associated [microglia](/cell-types/microglia-neuroinflammation) (DAM) — a protective microglial activation state discovered in [Alzheimer's disease](/diseases/alzheimers-disease) that is dependent on [TREM2](/proteins/trem2-protein) signaling. CLEC7A activates SYK kinase-dependent phagocytic and inflammatory programs through its hemITAM signaling motif.
CLEC7A / Dectin-1 Protein
Overview
CLEC7A (Dectin-1) is a type II transmembrane C-type lectin receptor (CLR) expressed primarily on [microglia](/cell-types/microglia) and other myeloid cells. Dectin-1 is the defining surface marker of disease-associated [microglia](/cell-types/microglia-neuroinflammation) (DAM) — a protective microglial activation state discovered in [Alzheimer's disease](/diseases/alzheimers-disease) that is dependent on [TREM2](/proteins/trem2-protein) signaling. CLEC7A activates SYK kinase-dependent phagocytic and inflammatory programs through its hemITAM signaling motif.
<div class="infobox infobox-protein"> [@brown2006]
<div class="infobox-header">CLEC7A / Dectin-1 Protein</div> [@krasemann2017]
<table> [@zhou2020]
<tr><td class="infobox-label">Protein Name</td><td>C-type Lectin Domain Family 7 Member A (Dectin-1)</td></tr> [@safaiyan2021]
<tr><td class="infobox-label">Gene</td><td>[CLEC7A](/genes/clec7a)</td></tr> [@goodridge2011]
<tr><td class="infobox-label">UniProt ID</td><td>[Q9BXN2](https://www.uniprot.org/uniprot/Q9BXN2)</td></tr> [@deczkowska2018]
<tr><td class="infobox-label">Molecular Weight</td><td>~28 kDa</td></tr> [@shah2021]
<tr><td class="infobox-label">Subcellular Localization</td><td>Plasma membrane (type II orientation)</td></tr>
<tr><td class="infobox-label">Protein Family</td><td>C-type lectin receptors (CLRs), Group V NK cell receptors</td></tr>
<tr><td class="infobox-label">Associated Diseases</td><td>[Alzheimer's disease](/diseases/alzheimers-disease), [Multiple Sclerosis](/diseases/multiple-sclerosis), [ALS](/diseases/amyotrophic-lateral-sclerosis)</td></tr>
</table>
</div>
Structure
CLEC7A is a 247 amino acid type II transmembrane glycoprotein:
Domain Architecture
- Cytoplasmic tail (aa 1–44): Contains a hemITAM motif (YxxxL) at Tyr-15 that recruits [SYK](/genes/syk) kinase upon phosphorylation. Unlike classical ITAM motifs (which have two YxxL sequences), the hemITAM is sufficient for SYK recruitment through receptor dimerization
- Transmembrane domain (aa 45–66): Single-pass type II orientation (N-terminus intracellular, C-terminus extracellular)
- Stalk region (aa 67–117): Flexible linker; contains an N-linked glycosylation site. The stalk enables dimerization, which is required for full signaling capacity
- C-type lectin-like domain (CTLD) (aa 118–247): Binds beta-1,3-glucan ligands. Despite being classified as a C-type lectin, Dectin-1 binds ligands in a calcium-independent manner. The CTLD adopts a compact fold with two alpha-helices, two antiparallel beta-sheets, and a ligand-binding groove
Oligomerization
Dectin-1 forms homodimers on the cell surface through its stalk region and CTLD. Dimerization brings two hemITAM motifs into proximity, enabling productive SYK recruitment (SYK has tandem SH2 domains that bridge two phospho-hemITAMs).
Splice Variants
Two major isoforms exist:
- Isoform A (full-length): Contains the stalk region; forms higher-order oligomers
- Isoform B (Δ stalk): Lacks the stalk; remains monomeric but retains ligand binding and some signaling capacity
Normal Function
Pattern Recognition
In the periphery, Dectin-1 is the primary receptor for beta-1,3-glucans on fungal cell walls, mediating antifungal innate immunity. In the CNS, Dectin-1 recognizes endogenous ligands:
- Damage-associated molecular patterns (DAMPs): Released from dying [neurons](/entities/neurons), including oxidized lipids and carbohydrates
- Myelin debris: During demyelination, exposed carbohydrate structures on damaged myelin are recognized by Dectin-1
- Amyloid-associated lipids: Modified lipoproteins in the plaque microenvironment
Signaling Cascade
Ligand binding triggers:
- CARD9/BCL10/MALT1 → [NF-κB](/genes/nfkb1) → pro-inflammatory cytokines (IL-1β, TNF, IL-6)
- PLCγ2 ([PLCG2](/genes/plcg2)) → NFAT → immune gene transcription
- PI3K/AKT → cell survival and metabolic reprogramming
- Raf-1 → noncanonical [NF-κB](/entities/nf-kb) → anti-inflammatory cytokine production (IL-10)
- NADPH oxidase ([NOX2](/genes/nox2)) → [ROS](/entities/reactive-oxygen-species) production for pathogen killing
Phagocytosis
Dectin-1 directly triggers phagocytic cup formation through SYK-dependent actin remodeling. In microglia, this mediates:
- [Amyloid-beta](/proteins/amyloid-beta) plaque phagocytosis
- Myelin debris clearance for remyelination
- Apoptotic neuron engulfment
- Synaptic pruning (complement-dependent and independent)
Role in Disease
Alzheimer's Disease — Disease-Associated Microglia
CLEC7A is one of the most robustly upregulated genes in DAM:
- Single-cell RNA-seq of 5xFAD mouse brains identified CLEC7A as a top Stage 2 DAM marker
- CLEC7A+ microglia form a physical barrier around amyloid plaques, compacting them and limiting neuritic dystrophy
- [TREM2](/genes/trem2) loss-of-function (e.g., R47H variant) prevents CLEC7A upregulation, locking microglia in a dysfunctional intermediate state
- Human AD brain single-nucleus RNA-seq confirms CLEC7A as a conserved DAM marker
- CLEC7A expression correlates with Braak stage and plaque density
Multiple Sclerosis
Dectin-1 has dual roles in demyelinating disease:
- Protective: Promotes myelin debris phagocytosis, enabling remyelination by [oligodendrocyte precursors](/cell-types/oligodendrocyte-precursor-cells)
- Pathogenic: Excessive Dectin-1 signaling can amplify inflammatory demyelination through IL-17 and GM-CSF production
ALS and Aging
CLEC7A marks activated microglia in the spinal cord of [SOD1](/genes/sod1) mice and in aging white matter (white matter-associated microglia, WAM). These populations share the DAM transcriptional signature.
Therapeutic Targeting
Beta-Glucan Agonists
- Systemic administration of particulate beta-glucan (curdlan, whole glucan particles) in AD mouse models enhances amyloid phagocytosis and improves cognition
- Trained immunity: Beta-glucan epigenetically reprograms myeloid cells for enhanced responsiveness, potentially providing long-lasting benefit
Indirect Modulation via TREM2
[TREM2](/proteins/trem2) agonist antibodies (AL002/latozinemab) in AD clinical trials promote CLEC7A upregulation by facilitating the Stage 1 → Stage 2 DAM transition.
See Also
- CLEC7A Gene
- [TREM2 Protein](/proteins/trem2-protein)
- [Microglia](/cell-types/microglia)
- SYK Gene
- [Disease-Associated Microglia](/cell-types/alzheimers-microglia)
External Links
- [UniProt: Q9BXN2](https://www.uniprot.org/uniprot/Q9BXN2)
- [PDB: 2CL8](https://www.rcsb.org/structure/2CL8)
- [GeneCards: CLEC7A](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CLEC7A)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | proteins-clec7a-protein |
| kg_node_id | CLEC7APROTEIN |
| entity_type | protein |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-7e7816fdb3d6 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-clec7a-protein'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-proteins-clec7a-protein?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[CLEC7A / Dectin-1 Protein](http://scidex.ai/artifact/wiki-proteins-clec7a-protein)
http://scidex.ai/artifact/wiki-proteins-clec7a-protein